Issue Navigation
-
Brief Report
-
243-246
Hashimoto H, Messerli SM, Sudo T, Maruta H
Drug Discov Ther. 2009; 3(6):243-246.
-
247-251
Pyrrolizidine alkaloid clivorine-induced oxidative stress injury in human normal liver L-02 cells.
Liang QN, Liu TY, Ji LL, Min Y, Xia YY
Drug Discov Ther. 2009; 3(6):247-251.
-
252-259
Takizawa N, Morita M, Adachi K, Watanabe K, Kobayashi N
Drug Discov Ther. 2009; 3(6):252-259.
-
260-265
A microplate-based screening assay for neuraminidase inhibitors.
Li AF, Wang WH, Xu WF, Gong JZ
Drug Discov Ther. 2009; 3(6):260-265.
-
266-271
Gonjari ID, Karmarkar AB, Kasture PV
Drug Discov Ther. 2009; 3(6):266-271.
-
272-277
Lan Y, Piao HR, Cui X
Drug Discov Ther. 2009; 3(6):272-277.
-
278-286
Handoussa H, Osmanova N, Ayoub N, Mahran L
Drug Discov Ther. 2009; 3(6):278-286.
-
287-295
Hanafy AFH, El-Egaky AM, Mortada SA, Molokhia AM
Drug Discov Ther. 2009; 3(6):287-295.
-
296-306
Abd El-Ghany RM, Sharaf NM, Kassem LA, Mahran LG, Heikal OA
Drug Discov Ther. 2009; 3(6):296-306.
-
307-315
El Sayed NS, Kassem LA, Heikal OA
Drug Discov Ther. 2009; 3(6):307-315.
-
316-318
-
319-322